135 related articles for article (PubMed ID: 26960924)
1. The normal-weight type 2 diabetes phenotype revisited.
Hermans MP; Amoussou-Guenou KD; Bouenizabila E; Sadikot SS; Ahn SA; Rousseau MF
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S82-8. PubMed ID: 26960924
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) in Chinese Beijing urban subjects.
Zhang Y; Fu J; Yang S; Yang M; Liu A; Wang L; Cao S; Sun X; Wang F; Liu D
Biosci Trends; 2017 Sep; 11(4):418-426. PubMed ID: 28740055
[TBL] [Abstract][Full Text] [Related]
3. Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease.
Kwon BJ; Kim DW; Her SH; Kim DB; Jang SW; Cho EJ; Ihm SH; Kim HY; Youn HJ; Seung KB; Kim JH; Rho TH
Metabolism; 2013 Jul; 62(7):952-60. PubMed ID: 23391273
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical and biochemical variables in type 2 diabetes mellitus patients and their first-degree relatives with metabolic syndrome in Benin City, Nigeria: A cross sectional case controlled study.
Ogedengbe S; Ezeani IU; Aihanuwa E
Endocr Regul; 2016 Jan; 50(1):32-40. PubMed ID: 27560635
[TBL] [Abstract][Full Text] [Related]
5. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey.
Pajunen P; Kotronen A; Korpi-Hyövälti E; Keinänen-Kiukaanniemi S; Oksa H; Niskanen L; Saaristo T; Saltevo JT; Sundvall J; Vanhala M; Uusitupa M; Peltonen M
BMC Public Health; 2011 Oct; 11():754. PubMed ID: 21962038
[TBL] [Abstract][Full Text] [Related]
6. High rates of atherogenic dyslipidemia, β-cell function loss, and microangiopathy among Turkish migrants with T2DM.
Hermans MP; Ahn SA; Sadikot S; Rousseau MF
Diabetes Metab Syndr; 2019; 13(1):716-720. PubMed ID: 30641794
[TBL] [Abstract][Full Text] [Related]
7. Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes.
Hermans MP; Ahn SA; Rousseau MF
J Diabetes Complications; 2019 Nov; 33(11):107413. PubMed ID: 31477553
[TBL] [Abstract][Full Text] [Related]
8. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation.
Venojärvi M; Korkmaz A; Wasenius N; Manderoos S; Heinonen OJ; Lindholm H; Aunola S; Eriksson JG; Atalay M
Food Chem Toxicol; 2013 Nov; 61():127-35. PubMed ID: 23623841
[TBL] [Abstract][Full Text] [Related]
9. Insulin Resistance and Diabetes Mellitus in Contemporary Cardiac Rehabilitation.
Khadanga S; Savage PD; Ades PA
J Cardiopulm Rehabil Prev; 2016; 36(5):331-8. PubMed ID: 27182762
[TBL] [Abstract][Full Text] [Related]
10. TOTAL BODY ADIPOSITY, TRIGLYCERIDES, AND LEG FAT ARE INDEPENDENT RISK FACTORS FOR DIABETIC PERIPHERAL NEUROPATHY IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS.
Zhen Q; Yao N; Chen X; Zhang X; Wang Z; Ge Q
Endocr Pract; 2019 Mar; 25(3):270-278. PubMed ID: 30913011
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
[TBL] [Abstract][Full Text] [Related]
12. Increased oxidative stress in normal-weight postmenopausal women with metabolic syndrome compared with metabolically healthy overweight/obese individuals.
Kim M; Paik JK; Kang R; Kim SY; Lee SH; Lee JH
Metabolism; 2013 Apr; 62(4):554-60. PubMed ID: 23142163
[TBL] [Abstract][Full Text] [Related]
13. The Relationship between Metabolically Obese Non-Obese Weight and Stroke: The Korea National Health and Nutrition Examination Survey.
Seo YG; Choi HC; Cho B
PLoS One; 2016; 11(8):e0160846. PubMed ID: 27494241
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and epidemiological determinants of metabolically obese but normal-weight in Chinese population.
Zheng Q; Lin W; Liu C; Zhou Y; Chen T; Zhang L; Zhang X; Yu S; Wu Q; Jin Z; Zhu Y
BMC Public Health; 2020 Apr; 20(1):487. PubMed ID: 32293373
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
Meis SB; Schuster D; Gaillard T; Osei K
Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
[TBL] [Abstract][Full Text] [Related]
16. Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes.
Camara S; Bouenizabila E; Hermans MP; Ahn SA; Rousseau MF
Diabetes Metab Syndr; 2014; 8(3):145-51. PubMed ID: 25220917
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in cardiometabolic health and disease in a cross-sectional observational obesity study.
Strack C; Behrens G; Sag S; Mohr M; Zeller J; Lahmann C; Hubauer U; Loew T; Maier L; Fischer M; Baessler A
Biol Sex Differ; 2022 Mar; 13(1):8. PubMed ID: 35246259
[TBL] [Abstract][Full Text] [Related]
18. Association between the metabolically healthy obese phenotype and the risk of myocardial infarction: results from the Kailuan study.
Xu Y; Li H; Wang A; Su Z; Yang G; Luo Y; Tao L; Chen S; Wu S; Wang Y; Guo X
Eur J Endocrinol; 2018 Dec; 179(6):343-352. PubMed ID: 30400019
[TBL] [Abstract][Full Text] [Related]
19. Sex- and BMI-related differences in risk factors for coronary artery disease in patients with type 2 diabetes mellitus.
Bo S; Gentile L; Cavallo-Perin P; Vineis P; Ghia V
Acta Diabetol; 1999 Sep; 36(3):147-53. PubMed ID: 10664319
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
